argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
870.00
-2.27 (-0.26%)
At close: Nov 11, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of $53.56 billion as of December 17, 2025. Its market cap has increased by 43.31% in one year.
Market Cap
53.56B
Enterprise Value
49.67B
Revenue
3.68B
Ranking
n/a
PE Ratio
34.93
Stock Price
$870.00
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 53.56B, an increase of 32,069.06%. That is a compound annual growth rate of 65.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 53.56B | 42.84% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | 13.95B | 102.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 789.81M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |